Radiomics Assess of Bevacizumab Plus Chemo in Colorectal Cancer Liver Metastases
NCT04213222
·
clinicaltrials.gov ↗
UNKNOWN
Status
300
Enrollment
OTHER
Sponsor class
Conditions
Colon Cancer
Rectal Cancer
Liver Metastases
Interventions
DRUG:
Bevacizumab
Sponsor
Peking University People's Hospital